What's New in Musculoskeletal Tumor Surgery
- PMID: 37874888
- DOI: 10.2106/JBJS.23.00833
What's New in Musculoskeletal Tumor Surgery
Conflict of interest statement
Disclosure: The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article ( http://links.lww.com/JBJS/H736 ).
References
-
- Brennan B, Kirton L, Marec-Bérard P, Gaspar N, Laurence V, Martín-Broto J, Sastre A, Gelderblom H, Owens C, Fenwick N, Strauss S, Moroz V, Whelan J, Wheatley K. Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Lancet. 2022 Oct 29;400(10362):1513-21.
-
- Richardson SM, Wurtz LD, Collier CD. Ninety percent or greater tumor necrosis is associated with survival and social determinants of health in patients with osteosarcoma in the National Cancer Database. Clin Orthop Relat Res. 2023 Mar 1;481(3):512-22.
-
- Kim Y, Park JW, Cho HS, Jang WY, Han I, Kim HS. Does the clinical presentation of secondary osteosarcoma in patients who survive retinoblastoma differ from that of conventional osteosarcoma and how do we detect them? Clin Orthop Relat Res. 2023 May 5.
-
- Gonzalez MR, Bedi A, Karczewski D, Lozano-Calderon SA. Are pathologic fractures in patients with osteosarcoma associated with worse survival outcomes? A systematic review and meta-analysis. Clin Orthop Relat Res. 2023 May 12.
-
- Gazendam AM, Schneider P, Bhandari M, Busse JW, Ghert M; on behalf of the PARITY Investigators. Defining minimally important differences in functional outcomes in musculoskeletal oncology. J Bone Joint Surg Am. 2022 Sep 21;104(18):1659-66.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
